Microstructural visual system changes in AQP4-antibody–seropositive NMOSD
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 1, 2016
- Accepted in final form January 10, 2017
- First Published February 22, 2017.
Author Disclosures
- Frederike C. Oertel*,
- Joseph Kuchling, MD*,
- Hanna Zimmermann, MEng,
- Claudia Chien, MSc,
- Felix Schmidt, MD,
- Benjamin Knier, MD,
- Judith Bellmann-Strobl, MD,
- Thomas Korn, MD,
- Michael Scheel, MD,
- Alexander Klistorner, MD,
- Klemens Ruprecht, MD,
- Friedemann Paul, MD and
- Alexander U. Brandt, MD
- Frederike C. Oertel*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Joseph Kuchling, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
JK received congress registration fee from Biogen andresearch support from Krankheitsbezogenes KompetenznetzMultiple Sklerose (KKNMS).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hanna Zimmermann, MEng,
NONE
NONE
(1) Commercial, Speaker honoraria from Teva(2) Commercial, Speaker honoraria from Bayer
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Claudia Chien, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Felix Schmidt, MD,
NONE
NONE
I received 130 Euros from Genzyme for a 5 min case presentation during a Meeting for neurologists sponsored by Genzyme.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Benjamin Knier, MD,
NONE
NONE
(1) Bayer, Travel Compensation(2) Merck Serono, Travel Compensation(3) ECTRIMS (non-profit), travel grant(4) Neurowind e.V. (non-profit), travel grant
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Kompetenznetz Multiple Sklerose (KKNMS), research grantfrom the Bundesministerium f?r Bildung und Forschung
Kommission f?r Klinische Foschung (KKF), intramuralresearch grant within the Technical University of Munich
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Judith Bellmann-Strobl, MD,
NONE
NONE
speaking fees and travel grants from Bayer Healthcare, sanofi-aventis/Genzyme, and Teva Pharmaceuticals
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thomas Korn, MD,
(1) German MS society(2) Merck Serono(3) Novartis(4) Biogen
NONE
(1) Biogen(2) Novartis(3) Merck Serono(4) Bayer
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Biogen
(1) German Research Council(2) German Ministry of Education and Research(3) European Research Council
NONE
Else-Kr?ner-Fresenius Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Michael Scheel, MD,
NONE
NONE
NONE
NONE
1) Patent for manufacturing of phantoms for computedtomography imaging with 3D printing technology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) Federal Ministry of Economics and Technology - EXISTProgramme Grant 03EFEBE079
NONE
NONE
NONE
NONE
NONE
NONE
- Alexander Klistorner, MD,
NONE
NONE
NONE
NONE
1. “Electrophysiological visual field measurement”Klistorner and Graham 1999, PCT/AU99/003402. “Method and apparatus for objectiveelectrophysiological assessment of visual function”Klistorner and Graham 2001, PCT/AU01/004233. ?Stimulus Method for Multifocal Visual EvokedPotential? Klistorner and Graham (Australian PatentApplication No 2007900803) 4. ?Flexible electrode assembly and apparatus formeasuring electrophysiological signals? Cheng, Klistorner,Graham (Australian Provisional Patent # 2006904755) 5. ?Apparatus for measuring electrophysiological signals?Cheng, Klistorner, Dyer - Australian Design No. 310666. 6. ? Flexible printed circuit board electrode assembly?Cheng, Klistorner, Dyer - Australian Design No. 311943.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Sydney University Foundation for Medical Research2. Sydney eye hospital foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Klemens Ruprecht, MD,
(1)sanofi-aventis/Genzyme(2)Novartis(3)Roche
NONE
(1)Bayer Healthcare, travel and speaker honoraria(2)Biogen Idec, travel and speaker honoraria(3)Merck Serono, travel and speaker honoraria(4)sanofi-aventis/Genzyme, travel and speaker honoraria(5)Teva Pharmaceuticals, travel and speaker honoraria(6)Novartis, travel and speaker honoraria(7)Guthy Jackson Charitable Foundation, travel honoraria
(1) PLOS ONE, Academic Editor, since 2013
NONE
(1) Neurologie in Frage und Antwort, Elsevier, 2000-2015
NONE
NONE
NONE
NONE
NONE
(1) Novartis
(1)German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Friedemann Paul, MD and
Novartis OCTIMS study steering committeeMedImmune steering committee
NONE
speaker honoraria and travel grants from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis / Genzyme, and Merck Serono, Alexion, Chugai, MedImmune, Shire
Academic Editor, PLoS ONEAssociate Editor, Neurology Neuroimmunology andNeuroinflammation
NONE
NONE
NONE
consultancies for SanofiGenzyme, BiogenIdec, MedImmune, Shire, Alexion
NONE
NONE
NONE
Research support from from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis / Genzyme, Alexion and Merck Serono
German Research Council (DFG Exc 257), Werth Stiftung of the City of Cologne, German Ministry ofEducation and Research (BMBF Competence Network MultipleSclerosis), Arthur Arnstein Stiftung Berlin, EU FP7Framework Program (combims.eu)
NONE
Arthur Arnstein Foundation Berlin, Guthy JacksonCharitable Foundation, National Multiple Sclerosis Societyof the USA
NONE
NONE
NONE
NONE
NONE
NONE
- Alexander U. Brandt, MD
(1) Biogen VISION study, scientific advisory board
NONE
(1) Novartis, funding for travel to conference(2) Biogen, funding for travel to conference(4) Teva, speaker honoraria
NONE
(1) Pending patent Method and System For OpticNerve Head Shape Quantification.(2) Pending patent Perceptive Visual Computingbased Postural Control Analysis.(3) Pending patent Multiple Sclerosis Biomarker.(4) Pending patent Perceptive Sleep MotionAnalysis
NONE
NONE
(1) Nexus, Hospital Information Systems(2) Motognosis
NONE
NONE
NONE
(1) Novartis Pharma(2) Biogen Idec
(1) BMWi, ZIM KF2443803KJ, PI, two years(2) BMWi, ZIM KF2291305AK3, Co-I, one year(3) BMWI, EXIST-FT 03EFEBE079, PI, two years(4) BMBF, NEU2 N2-ADVISIMS, Co-I, three years
NONE
(1) The Guthy Jackson Charitabke Foundation
NONE
NONE
NONE
NONE
(1) Motognosis, 2014 (ongoing)
NONE
- From the NeuroCure Clinical Research Center (F.C.O., J.K., H.Z., C.C., F.S., J.B.-S., M.S., F.P., A.U.B.), and Department of Neurology (J.K., F.S., J.B.-S., K.R., F.P.), Charité—Universitätsmedizin Berlin; Department of Neurology (B.K., T.K.), Klinikum rechts der Isar, and Department of Experimental Neuroimmunology (T.K.), Technische Universität München; Munich Cluster for Systems Neurology (SyNergy) (T.K.), Germany; Clinical Ophthalmology and Eye Health (A.K.), Central Clinical School, Save Sight Institute, Sydney, Australia; and Experimental and Clinical Research Center (F.P.), Max Delbrueck Center for Molecular Medicine and Charité—Universitätsmedizin Berlin, Germany.
- Correspondence to Dr. Brandt: alexander.brandt{at}charite.de
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesionsAlexander Klistorner, Prima Sriram, Nikitha Vootakuru et al.Neurology, May 16, 2014 -
Articles
Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathiesJ. N. Ratchford, M. E. Quigg, A. Conger et al.Neurology, July 27, 2009 -
Article
Optical coherence tomography is highly sensitive in detecting prior optic neuritisSarah Chaoying Xu, Randy H. Kardon, Jacqueline A. Leavitt et al.Neurology, January 23, 2019 -
Article
In vivo identification of morphologic retinal abnormalities in neuromyelitis opticaElias S. Sotirchos, Shiv Saidha, Gita Byraiah et al.Neurology, March 20, 2013